Industrial and Intellectual Property

Dip_Amministrativo_191229458

17 Jan: Assogenerici with Pavia e Ansaldo obtains Pfizer’s condemnation for abuse of a dominant position

Assogenerici with Pavia e Ansaldo obtains Pfizer’s condemnation for abuse of a dominant position Confirmation of the administrative fine imposed by the Italian Antitrust Authority on Pfizer for obstructing the entrance of latanoprost Milan, 17 January 2014 – Pavia e Ansaldo assisted Assogenerici, the association of the manufacturers of generics in Italy, in the proceedings before the Consiglio di Stato (Supreme Administrative Court), against Pfizer Italia, its relevant European parent company as well as the American one, that found Pfizer companies responsible for abuse of a dominant position and imposed on them a fine of more than EUR 10 million for…